Your browser doesn't support javascript.
loading
Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity.
Liu, Jacey J; Xin, Bing; Du, Li; Chen, Lydia; Long, Yanyan; Feng, Gen-Sheng.
Afiliación
  • Liu JJ; Department of Molecular Biology , School of Biological Sciences , University of California at San Diego , La Jolla , California , USA.
  • Xin B; Department of Pathology and Moores Cancer Center , School of Medicine , University of California at San Diego , La Jolla , California , USA.
  • Du L; Department of Pathology and Moores Cancer Center , School of Medicine , University of California at San Diego , La Jolla , California , USA.
  • Chen L; Department of Molecular Biology , School of Biological Sciences , University of California at San Diego , La Jolla , California , USA.
  • Long Y; Department of Pathology and Moores Cancer Center , School of Medicine , University of California at San Diego , La Jolla , California , USA.
  • Feng GS; Department of Molecular Biology , School of Biological Sciences , University of California at San Diego , La Jolla , California , USA.
Hepatology ; 77(5): 1512-1526, 2023 05 01.
Article en En | MEDLINE | ID: mdl-35503714

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Hepatology Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Hepatology Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos